Dichloroacetic Acid (DCA)-Induced Cytotoxicity in Human Breast Cancer Cells Accompanies Changes in Mitochondrial Membrane Permeability and Production of Reactive Oxygen Species — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Dichloroacetic Acid (DCA)-Induced Cytotoxicity in Human Breast Cancer Cells Accompanies Changes in Mitochondrial Membrane Permeability and Production of Reactive Oxygen Species
College of Science, University of Diyala, Baquba, Iraq
,
Department of Biology, College of Arts, Letters and Sciences, University of Arkansas at Little Rock, Little Rock, USA
,
Department of Biology, College of Arts, Letters and Sciences, University of Arkansas at Little Rock, Little Rock, USA
,
Department of Internal Medicine, Division of Rheumatology, University of Arkansas for Medical Sciences, Little Rock, USA
,
Department of Biology, College of Arts, Letters and Sciences, University of Arkansas at Little Rock, Little Rock, USA
1 College of Science, University of Diyala, Baquba, Iraq
2 Department of Biology, College of Arts, Letters and Sciences, University of Arkansas at Little Rock, Little Rock, USA
3 Department of Biology, College of Arts, Letters and Sciences, University of Arkansas at Little Rock, Little Rock, USA
4 Department of Internal Medicine, Division of Rheumatology, University of Arkansas for Medical Sciences, Little Rock, USA
5 Department of Biology, College of Arts, Letters and Sciences, University of Arkansas at Little Rock, Little Rock, USA
Cancer cells utilize cytosolic glycolysis for their energy production even in the presence of adequate levels of oxygen (Warbug effect) due to mitochondrial defects. Dichloroacetic acid (DCA) shifts cytosolic glucose metabolism to aerobic oxidation by inhibiting mitochondrial pyruvate dehydrogenase kinase (PDK) and increasing pyruvate uptake. Therefore, DCA has potential in reversing the glycolytic metabolism defect in cancerous cells. DCA is also known to induce apoptosis in a number of cancer cell lines, the mechanism of which is not well understood. In this study, an attempt has been made to investigate the effects of DCA on aggressive human breast cancer (MCF-7) cells as compared with less aggressive mouse osteoblastic (MC3T3) cells. Cell cytotoxicity was determined by MTT, crystal violet and Trypan blue exclusion assays. Western blot was used to detect any changes in the expression of apoptotic markers. Flow cytometry was used to measure apoptotic and necrotic effects of DCA. Mitochondrial integrity was determined by change in mitochondrial membrane potential (Δψm), whereas oxidative damage was determined by production of reactive oxygen species (ROS). DCA caused a concentration-dependent cytotoxicity both in MCF-7 and MC3T3 cell lines. MCF-7 cells were most affected. Flow cytometry results showed a significantly higher apoptosis in MCF-7 even at lower concentrations of DCA. However, higher concentrations of DCA were necrotic. Western blotting showed an increased expression of Mn-SOD-1 upon DCA treatment. Further, DCA decreased Δψm and increased ROS production. The effects of DCA were more pronounced on MCF-7 cells as compared to MC3T3 cells. Our results suggest that DCA-induced cytotoxicity in cancerous cells is mediated via changes in Δψm and production of ROS.
KeywordsBreast CancerDichloroacetic AcidDCACancer TherapyAnticancer AgentsApoptosisMitochondrial DefectsReactive Oxygen Species (ROS)
Wu, W. and Zhao, S. (2013) Metabolic Changes in Cancer: Beyond the Warburg Effect. Acta Biochimica et Biophysica Sinica (Shanghai), 45, 18-26. http://dx.doi.org/10.1093/abbs/gms104
Bonnet, S., Archer, S., Alalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., et al. (2007) A Mitochondria-K Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth. Cancer Cell, 11, 37-51. http://dx.doi.org/10.1016/j.ccr.2006.10.020
Heshe, D., Hoogestraat, S., Brauckmann, C., Karst, U., Boos, J. and Lanvers-Kaminsky, C. (2011) Dichloroacetate Metabolically Targeted Therapy Defeats Cytotoxicity of Standard Anticancer Drugs. Cancer Chemotherapy and Pharmacology, 67, 647-655. http://dx.doi.org/10.1007/s00280-010-1361-6
Papandreou, I., Goliasova, T. and Denko, N.C. (2011) Anticancer Drugs That Target Metabolism: Is Dichloroacetate the New Paradigm? International Journal of Cancer, 128, 1001-1008. http://dx.doi.org/10.1002/ijc.25728
Michelakis, E., Webster, L. and Mackey, J. (2008) Dichloroacetate (DCA) as a Potential Metabolic-Targeting Therapy for Cancer. British Journal of Cancer, 99, 989-994. http://dx.doi.org/10.1038/sj.bjc.6604554
Wong, J.Y., Huggins, G.S., Debidda, M., Munshi, N.C. and De Vivo, I. (2008) Dichloroacetate Induces Apoptosis in Endometrial Cancer Cells. Gynecologic Oncology, 109, 394-402. http://dx.doi.org/10.1016/j.ygyno.2008.01.038
Stacpoole, P.W., Gilbert, L.R., Neiberger, R.E., Carney, P.R., Valenstein, E., Theriaque, D.W. and Shuster, J.J. (2008) Evaluation of Long-Term Treatment of Children with Congenital Lactic Acidosis with Dichloroacetate. Pediatrics, 121, e1223-e1228. http://dx.doi.org/10.1542/peds.2007-2062
Mosmann, T. (1983) Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays. Journal of Immunological Methods, 65, 55-63. http://dx.doi.org/10.1016/0022-1759(83)90303-4
Flick, D.A. and Gifford, G.E. (1984) Comparison of in Vitro Cell Cytotoxic Assays for Tumor Necrosis Factor. Journal of Immunological Methods, 68, 167-175. http://dx.doi.org/10.1016/0022-1759(84)90147-9
Isakovic, A., Markovic, Z., Todorovic-Markovic, B., Nikolic, N., Vranjes-Djuric, S., Mirkovic, M., Dramicanin, M., Harhaji, L., Raicevic, N., Nikolic, Z. and Trajkovic, V. (2006) Distinct Cytotoxic Mechanisms of Pristine versus Hydroxylated Fullerene. Toxicological Sciences, 91, 173-183. http://dx.doi.org/10.1093/toxsci/kfj127
Krmpot, A.J., Janjetovic, K.D., Misirkic, M.S., Vucicevic, L.M., Pantelic, D.V., Vasiljevic, D.M., Popadic, D.M., Jelenkovic, B.M. and Trajkovic, V.S. (2010) Protective Effect of Autophagy in Laser-Induced Glioma Cell Death in Vitro. Lasers in Surgery and Medicine, 42, 338-347. http://dx.doi.org/10.1002/lsm.20911
Agarwal, R., Mumtaz, H. and Ali, N. (2009) Role of Inositol Polyphosphates in Programmed Cell Death. Molecular and Cellular Biochemistry, 328, 155-165. http://dx.doi.org/10.1007/s11010-009-0085-6
Cao, W., Yacoub, S., Shiverick, K.T., Namiki, K., Sakai, Y., Porvasnik, S., Urbanek, C. and Rosser, C.J. (2008) Dichloroacetate (DCA) Sensitizes Both Wild-Type and over Expressing Bcl-2 Prostate Cancer Cells in Vitro to Radiation. Prostate, 68, 1223-1231. http://dx.doi.org/10.1002/pros.20788
Chen, Y., Cairns, R., Papandreou, I., Koong, A. and Denko, N.C. (2009) Oxygen Consumption Can Regulate the Growth of Tumors, a New Perspective on the Warburg Effect. PLoS ONE, 4, e7033. http://dx.doi.org/10.1371/journal.pone.0007033
Michelakis, E.D., Sutendra, G., Dromparis, P., Webster, L., Haromy, A., Niven, E., Maguire, C., Gammer, T.L., Mackey, J.R., Fulton, D., Abdulkarim, B., McMurtry, M.S. and Petruk, K.C. (2010) Metabolic Modulation of Glioblastoma with Dichloroacetate. Science Translational Medicine, 2, 31ra34. http://dx.doi.org/10.1126/scitranslmed.3000677
Sun, R.C., Fadia, M., Dahlstrom, J.E., Parish, C.R., Board, P.G. and Blackburn, A.C. (2010) Reversal of the Glycolytic Phenotype by Dichloroacetate Inhibits Metastatic Breast Cancer Cell Growth in Vitro and in Vivo. Breast Cancer Res Treat, 120, 253-260. http://dx.doi.org/10.1007/s10549-009-0435-9
Hsu, P.P. and Sabatini, D.M. (2008) Cancer Cell Metabolism: Warburg and Beyond. Cell, 134, 703-707. http://dx.doi.org/10.1016/j.cell.2008.08.021
Madhok, B., Yeluri, S., Perry, S., Hughes, T. and Jayne, D. (2010) Dichloroacetate Induces Apoptosis and Cell-Cycle Arrest in Colorectal Cancer Cells. British Journal of Cancer, 102, 1746-1752. http://dx.doi.org/10.1038/sj.bjc.6605701
Sun, R.C., Board, P.G. and Blackburn, A.C. (2011) Targeting Metabolism with Arsenic Trioxide and Dichloroacetate in Breast Cancer Cells. Molecular Cancer, 10, 142. http://dx.doi.org/10.1186/1476-4598-10-142
Xie, J., Wang, B., Yu, D., Lu, Q., Ma, J., Qi, H., Fang, C. and Chen, H. (2011) Dichloroacetate Shifts the Metabolism from Glycolysis to Glucose Oxidation and Exhibits Synergistic Growth Inhibition with Cisplatin in Hela Cells. International Journal of Oncology, 38, 409-417.
Shahrzad, S., Lacombe, K., Adamcic, U., Minhas, K. and Coomber, B.L. (2010) Sodium Dichloroacetate (DCA) Reduces Apoptosis in Colorectal Tumor Hypoxia. Cancer Letters, 297, 75-83. http://dx.doi.org/10.1016/j.canlet.2010.04.027
Soule, H.D., Vazguez, J., Long, A., Albert, S. and Brennan, M. (1973) A Human Cell Line from a Pleural Effusion Derived from a Breast Carcinoma. Journal of the National Cancer Institute, 51, 1409-1416.
Burdall, S.E., Hanby, A.M., Lansdown, M. and Speirs, V. (2003) Breast Cancer Cell Lines: Friend or Foe? Breast Cancer Research, 5, 89-95. http://dx.doi.org/10.1186/bcr577
Bilezikian, J.P., Raisz, L.G. and Martin, T.J. (2008) Principles of Bone Biology: Two-Volume Set. Academic Press, Waltham.
Ko, L. and Allalunis-Turner, J. (2009) Investigation on the Mechanism of Dichloroacetate (DCA) Induced Apoptosis in Breast Cancer. Journal of Clinical Oncology, 27, e14637.
Gatenby, R.A. and Gillies, R.J. (2004) Why Do Cancers Have High Aerobic Glycolysis? Nature Reviews Cancer, 4, 891-899. http://dx.doi.org/10.1038/nrc1478
Kinnula, V.L. and Crapo, J.D. (2004) Superoxide Dismutases in Malignant Cells and Human Tumors. Free Radical Biology and Medicine, 36, 718-744. http://dx.doi.org/10.1016/j.freeradbiomed.2003.12.010
Tandon, V.R., Sharma, S., Mahajan, A. and Bardi, G.H. (2005) Oxidative Stress: A Novel Strategy in Cancer Treatment. JK Science, 7, 1-3.
Saed, G.M., Fletcher, N.M., Jiang, Z.L., Abu-Soud, H.M. and Diamond, M.P. (2011) Dichloroacetate Induces Apoptosis of Epithelial Ovarian Cancer Cells through a Mechanism Involving Modulation of Oxidative Stress. Reproductive Sciences, 18, 1253-1261. http://dx.doi.org/10.1177/1933719111411731
Hileman, E.O., Liu, J., Albitar, M., Keating, M.J. and Huang, P. (2004) Intrinsic Oxidative Stress in Cancer Cells: A Biochemical Basis for Therapeutic Selectivity. Cancer Chemotherapy and Pharmacology, 53, 209-219. http://dx.doi.org/10.1007/s00280-003-0726-5
Bhosle, S., Pandey, B., Huilgol, N. and Mishra, K. (2003) Membrane Oxidative Damage and Apoptosis in Cervical Carcinoma Cells of Patients after Radiation Therapy. In: Advanced Flow Cytometry: Applications in Biological Research, Springer, Berlin, 65-68.
Huang, P., Feng, L., Oldham, E.A., Keating, M.J. and Plunkett, W. (2000) Superoxide Dismutase as a Target for the Selective Killing of Cancer Cells. Nature, 407, 390-395. http://dx.doi.org/10.1038/35030140
Reuter, S., Gupta, S.C., Chaturvedi, M.M. and Aggarwal, B.B. (2010) Oxidative Stress, Inflammation, and Cancer: How Are They Linked? Free Radical Biology and Medicine, 49, 1603-1616. http://dx.doi.org/10.1016/j.freeradbiomed.2010.09.006
Lingohr, M.K., Thrall, B.D. and Bull, R.J. (2001) Effects of Dichloroacetate (DCA) on Serum Insulin Levels and Insulin-Controlled Signaling Proteins in Livers of Male B6C3F1 Mice. The Journal of Toxicological Sciences, 59, 178-184. http://dx.doi.org/10.1093/toxsci/59.1.178
Bates, R.C., Edwards, N.S., Burns, G.F. and Fisher, D.E. (2001) A CD44 Survival Pathway Triggers Chemoresistance via Lyn Kinase and Phosphoinositide 3-Kinase/Akt in Colon Carcinoma Cells. Cancer Research, 61, 5275-5283.
Pelicano, H., Xu, R.H., Du, M., Feng, L., Sasaki, R., Carew, J.S., Hu, Y., Ramdas, L., Hu, L., Keating, M.J., Zhang, W., Plunkett, W. and Huang, P. (2006) Mitochondrial Respiration Defects in Cancer Cells Cause Activation of Akt Survival Pathway through a Redox-Mediated Mechanism. The Journal of Cell Biology, 175, 913-923. http://dx.doi.org/10.1083/jcb.200512100